Modulation of bleomycin-induced mitotic
โ
Hoffmann, George R. ;Quaranta, Joseph L. ;Shorter, Rose A. ;Littlefield, L. Gayl
๐
Article
๐
1995
๐
Springer
๐
English
โ 991 KB
The cancer chemotherapy drug bleomycin (BLM) is a potent inducer of genetic damage in a wide variety of assays. The radioprotectors cysteamine (CSM) and WR-1065 have been shown in previous studies to potentiate the induction of micronuclei and chromosome aberrations by BLM in Go human lymphocytes. B